Table 2.
HBAC HAART program: Incremental costs, benefits and cost-effectiveness results over two years.
| Costs, health benefits and cost-effectiveness | |
|---|---|
| Program cost for 1,000 clients | $1,386,670 |
| Cost of ART for deaths prevented | $3,634,353 |
| Program cost plus costs of HAART for deaths prevented in first two years | $5,021,023 |
| Savings in opportunistic infection treatment costs | ($247,750) |
| Cost net of opportunistic HIV infections prevented | $4,773,273 |
| Savings in new infant and adult HIV cases prevented | ($677,815) |
| Cost net of illness and new adult and infant HIV infections prevented | $4,095,458 |
| DALYs averted (deaths and infections prevented; incl. deaths prevented in HIV-neg. children) | 6,791 |
| DALYs averted through MTCT | 70 |
| Total DALYs averted | 6,861 |
| Net cost per DALY averted | $597 |